Carol Schafer - May 31, 2023 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
Teresa Bair, Attorney-in-fact for Carol Schafer
Stock symbol
KURA
Transactions as of
May 31, 2023
Transactions value $
$0
Form type
4
Date filed
6/2/2023, 05:00 PM
Previous filing
May 15, 2023
Next filing
Jun 12, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +26K $0.00 26K May 31, 2023 Common Stock 26K $13.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full on the one year anniversary of the date of grant.